This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Centre National De La Recherche Scientifique. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Oussama Meziane: Innovator in Retrovirus Treatment
Introduction
Oussama Meziane is a notable inventor based in Montpellier, France. He has made significant contributions to the field of medical research, particularly in the treatment of retrovirus infections. His innovative work has led to the development of a patent that addresses critical health challenges.
Latest Patents
Oussama Meziane holds a patent for "Compositions and methods for treating retrovirus infections." This invention relates to at least one nucleic acid that comprises or consists of a sequence selected from a specific group. The patent outlines a method for inducing HIV-1 expression in latent HIV-1-infected cells, providing a potential avenue for treating retrovirus infections. He has 1 patent to his name, showcasing his commitment to advancing medical science.
Career Highlights
Oussama Meziane is affiliated with the Centre National de la Recherche Scientifique, a prestigious research institution in France. His work at this institution has allowed him to focus on groundbreaking research that has the potential to impact public health significantly. His dedication to innovation in the medical field is evident through his research and patent contributions.
Collaborations
Oussama has collaborated with esteemed colleagues, including Monsef Benkirane and Robinson Triboulet. These partnerships have fostered a collaborative environment that enhances the quality and impact of their research efforts.
Conclusion
Oussama Meziane is a prominent figure in the field of retrovirus treatment, with a focus on innovative solutions to complex health issues. His contributions through patents and collaborations highlight his role as a key inventor in medical research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
